Furthermore, single gene targeting in vitro in some cases generated not just one but multiple mutational signatures, buttressing previous reports that multiple in vivo cancer-derived signatures could arise from single gene defects such as in BRCA1/BRCA217. The gene discussed is BRCA1; the disease is cancer.